Profile image
Story Views

Last Hour:
Last 24 Hours:

Contact Dermatitis Pipeline Review, H2 2016: Therapeutics Analysis by Stage of Development, Drug Target, MoA, RoA & Molecule Type

Friday, November 11, 2016 2:49
% of readers think this story is Fact. Add your two cents.

Latest Contact Dermatitis Pipeline Review, H2 2016, provides in depth analysis on Cellular Tumor Antigen P53 (Tumor Suppressor P53 or Antigen NY-CO-13) targeted pipeline therapeutics.

Contact Dermatitis therapeutics industry report provides comprehensive information on the therapeutics under development for Contact Dermatitis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Contact Dermatitis and features dormant and discontinued projects.

Browse more detail information about Contact Dermatitis market report at:

Contact dermatitis is a type of skin inflammation that occurs when substances touching skin cause irritation or an allergic reaction. Signs and symptoms of contact dermatitis include red rash or bumps, dry, cracked, red patches, which may resemble a burn and pain or tenderness. There are two types of contact dermatitis; irritant and allergic. Irritant dermatitis, the most common type, is caused by contact with acids, alkaline materials such as soaps and detergents, fabric softeners, solvents, or other chemicals. The reaction usually looks like a burn. Allergic contact dermatitis is an itchy skin condition caused by an allergic reaction to allergen. Treatment includes oral corticosteroids and antihistamines to relieve intense itching.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Key players in Contact Dermatitis – Pipeline Review, H2 2016:

  • Aldeyra Therapeutics Inc
  • Anacor Pharmaceuticals, Inc.
  • AskAt Inc.
  • Brickell Biotech, Inc.
  • Dr. August Wolff GmbH & Co. KG Arzneimittle
  • Edesa Biotech Inc
  • Hapten Sciences, Inc.
  • ILiAD Biotechnologies, LLC
  • LegoChem Biosciences, Inc
  • Marinomed Biotechnologie GmbH
  • Novartis AG
  • Signum Dermalogix, Inc
  • Sucampo Pharmaceuticals, Inc.

Get a PDF Sample of Contact Dermatitis Market Research Report at:


Drug Profiles of Included in Contact Dermatitis Therapeutics Development Market Report

  • AAT-008
  • ADX-102
  • BBI-2000
  • HPT-721
  • secukinumab

And other drug profiles

Have any query? ask our expert @

Key Topics Covered:
2.Contact Dermatitis Overview
3.Contact Dermatitis Therapeutics Development
4.Pipeline Products for Contact Dermatitis – Overview
5.Pipeline Products for Contact Dermatitis – Comparative Analysis
6.Contact Dermatitis – Therapeutics under Development by Companies
7.Contact Dermatitis – Therapeutics under Investigation by Universities/Institutes
8.Contact Dermatitis Products Glance
9.Late Stage Products
10.Clinical Stage Products
11.Early Stage Products
12.Contact Dermatitis – Products under Development by Companies
13.Contact Dermatitis – Products under Investigation by Universities/Institutes
14.Contact Dermatitis – Companies Involved in Therapeutics Development
15.Contact Dermatitis Drug Profiles
16.Contact Dermatitis Dormant Projects
17.Contact Dermatitis Discontinued Products
18.Contact Dermatitis Featured News & Press Releases
And Continue…

Get Discount on Contact Dermatitis Market Research Report at:

This research study help to:
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of therapeutics under development for Contact Dermatitis
- Identify potential new clients or partners in the target demographic
- Develop strategic initiatives by understanding the focus areas of leading companies
- Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding Contact Dermatitis pipeline depth and focus of Indication therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline


About Absolute Report:

Absolute Reports is an upscale platform to help key personnel in the business world in strategizing and taking visionary decisions based on facts and figures derived from in depth market research. We are one of the top report resellers in the market, dedicated towards bringing you an ingenious concoction of data parameters.


Mr. Ameya Pingaley

Absolute Reports

+1-408 520 9750

Email –

We encourage you to Share our Reports, Analyses, Breaking News and Videos. Simply Click your Favorite Social Media Button and Share.

Report abuse


Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

Top Stories
Recent Stories



Top Global


Top Alternative




Email this story
Email this story

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.